49 Results for "

Free Fatty Acid Receptor

" in MedChemExpress (MCE) Product Catalog:
Products (49)

49 Results for "Free Fatty Acid Receptor" in MCE Product Catalog:

18
18 Publications Verification
Referencia número: HY-12940
No. CAS: 1391076-61-1
Pureza:  98.12%
Áreas de investigación:  

Metabolic Disease

GLPG0974 is a free fatty acid receptor-2 (FFA2/GPR43) antagonist with an IC50 of 9 nM.
loading...
    loading...
14
14 Cited Publications
Referencia número: HY-100881
No. CAS: 1374516-07-0
Pureza:  99.47%
Áreas de investigación:  

Metabolic Disease

TUG-891 is a potent and selective agonist for the long chain free fatty acid (LCFA) receptor 4 (FFA4/GPR120) .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-P1125
No. CAS: 300851-67-6
Áreas de investigación:  

Others

4-CMTB is a selective free fatty acid receptor 2 (FFA2/GPR43) agonist and a positive allosteric modulator (pEC50=6.38) .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-W016868
No. CAS: 53984-36-4
Áreas de investigación:  

Metabolic Disease

3-Chloro-5-hydroxybenzoic acid is a potent, orally active and selective lactate receptor GPR81 agonist, with an EC50 of 16 μM for human GPR81. 3-Chloro-5-hydroxybenzoic acid exhibits favorable in vivo effects on lipolysis in a mouse model of obesity .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-112813
No. CAS: 2247372-59-2
Pureza:  99.42%
Áreas de investigación:  

Metabolic Disease

TUG-1375 is an agonist of free fatty acid receptor 2 (FFA2/GPR43), with a pKi of 6.69. TUG-1375 is inactive on FFA3, FFA4, PPARα, PPARγ, PPARδ, LXRα or LXRβ .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-116522
No. CAS: 1798310-55-0
Pureza:  98.29%
AR420626 is a selective agonist of free fatty acid receptor 3 (FFAR3) (IC50=117 nM). AR420626 has anti-inflammatory, anticancer and antidiabetic activities. AR420626 improves neurogenic diarrhea by inhibiting nAChR mediated neural pathways. AR420626 inhibits the growth of HepG2 xenografts and inhibits the proliferation of hepatoma cells by inducing apoptosis. AR420626 also suppresses allergic asthma and eczema and has the ability to activate GPR41 to increase Ca 2+ signal-mediated glucose uptake and improve diabetes .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-N1478
No. CAS: 24512-62-7
Gardenoside is an orally active natural compound found in Gardenia fruits. Gardenoside reliefs chronic constriction injury (CCI)-induced neuropathic pain by regulating the P2X3 and P2X7 receptors. Gardenoside has an inhibitory effect on free fatty acids (FFA)-induced cellular steatosis. Gardenoside reduces reactive oxygen species (ROS). Gardenoside can be used for anti-inflammatory, antinociceptive and hepatoprotective study .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-116263
No. CAS: 1322598-09-3
Pureza:  99.7%
Áreas de investigación:  

Metabolic Disease

CATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-W040127
No. CAS: 6906-39-4
Peonidin 3-O-glucoside chloride is an agonist of the free fatty acid receptor FFAR1 and Glucokinase. Peonidin 3-O-glucoside chloride enhances insulin secretion of pancreatic beta cells and increases glucose uptake by liver cells. Peonidin 3-O-glucoside chloride activates FFAR1, promotes the phosphorylation of related proteins in the insulin secretion pathway, and increases the expression of FFAR1. In liver cells, Peonidin 3-O-glucoside chloride activates GK and regulates proteins associated with carbohydrate metabolism. Peonidin 3-O-glucoside chloride can be used in diabetes research .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-19995
No. CAS: 349085-82-1
Synonyms: GSK 137647
Áreas de investigación:  

Metabolic Disease

GSK137647A (GSK 137647) is a potent, selective free fatty acid receptor 4 (FFA4) agonist with pEC50 values of 6.3, 6.2, and 6.1 for human, mouse and rat FFA4, and pEC50 values < 4.5 for all three species for FFA1, FFA2, and FFA3, respectively. GSK137647A has anti-inflammatory activity. GSK137647A induces insulin secretion and inhibits epithelial ion transport, GSK137647A is related to regulation of glucose homeostasis and anti-inflammatory response .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-111143
No. CAS: 915210-50-3
Pureza:  98.64%
Target:  

nAChR

Áreas de investigación:  

Metabolic Disease

SCH-900271 is an orally active, potent nicotinic acid receptor (NAR) agonist with an EC50 of 2 nM in the hu-GPR109a assay. SCH-900271 exhibits dose-dependent inhibition of plasma free fatty acid (FFA) .
loading...
    loading...
Referencia número: HY-W145665
No. CAS: 9005-82-7
Amylose is not a typical small-molecule ligand with a specific traditional receptor-binding target. It is a polysaccharide. In food science and biological systems, amylose can interact with proteins and free fatty acids through non-covalent forces like hydrophobic interactions and electrostatic interactions. For example, it can form a ternary complex with them, which is related to the structure and digestion of starch. It is widely studied in the fields of food science, carbohydrate metabolism, and is also relevant in research on controlling glycemic responses, as it affects starch digestion rate .
loading...
    loading...
Referencia número: HY-124571
No. CAS: 376616-73-8
Pureza:  99.88%
Target:  

GPR84

Áreas de investigación:  

Inflammation/Immunology

ZQ-16 is a potent and selective GPR84 agonist with an EC50 value of 0.213 μM. ZQ-16 has no activity on the other free fatty acid receptors (FFARs), including GPR40, GPR41, GPR119 and GPR120 .
loading...
    loading...
Referencia número: HY-W009081
No. CAS: 2433-96-7
Tricosanoic acid is an endogenous agonist of long-chain saturated fatty acids and free fatty acid receptor FFAR1, which can activate hair growth. Tricosanoic acid (C23:0) has the activity of improving cognitive function by regulating neuronal membrane fluidity, inhibiting neuroinflammatory response, participating in myelination and neuronal energy metabolism. Tricosanoic acid expression levels are low in the prefrontal cortex of Alzheimer's disease (AD) models; while better cognitive performance corresponds to higher serum concentration levels. Tricosanoic acid can be used as a biomarker for diseases related to cognitive decline .
loading...
    loading...
Referencia número: HY-123297
No. CAS: 1236109-67-3
Pureza:  99.90%
Áreas de investigación:  

Metabolic Disease

TUG-469 is a selective free fatty acid receptor 1 (FFA1/GPR40) agonist with an EC50 value of 19 nM. TUG-469 is >200-fold selective for FFA1 over FFA4. TUG-469 significantly improves glucose tolerance in pre-diabetic mice. TUG-469 can be used for the research of diabetes .
loading...
    loading...
Referencia número: HY-148418
No. CAS: 1206629-08-4
Pureza:  99.78%
Áreas de investigación:  

Metabolic Disease

TUG-499 is a selective free fatty acid receptor 1 (FFAR1 or GPR40) (Free Fatty Acid Receptor) agonist with a pEC50 of 7.39. TUG-499 exhibits >100-fold selectivity over the related receptors FFA2, FFA3, and the nuclear receptor PPARγ and other diverse receptors, ion channels, and transporters. TUG-499 can be used for the research of type 2 diabetes . TUG-499 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Referencia número: HY-133178
No. CAS: 131086-98-1
Pureza:  99.72%
Synonyms: 3,4,8,9-Tetrahydroxy urolithin
Urolithin D (3,4,8,9-Tetrahydroxy urolithin) is a colonic metabolite of Ellagitannins and a competitive, reversible, and selective antagonist of the EphA receptor. Urolithin D inhibits EphA2-ephrin-A1 binding with an IC50 of 0.9 μM. Urolithin D is also a potent antioxidant that scavenges free radicals and repairs oxidized DNA damage. Additionally, Urolithin D suppresses triglyceride accumulation and promotes fatty acid oxidation by activating the AMPK signaling pathway. Urolithin D can be used for research on tumors, metabolic, and inflammatory diseases .
loading...
    loading...
Referencia número: HY-103083
No. CAS: 2102196-57-4
Pureza:  98.38%
Áreas de investigación:  

Metabolic Disease

GPR40 agonist 4 is a potent free fatty acid receptor 1 (FFA1/ GPR40) agonist with a pEC50 of 7.54.
loading...
    loading...
Referencia número: HY-14363
No. CAS: 1082058-99-8
Áreas de investigación:  

Metabolic Disease

TUG-424 is a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with an EC50 of 32 nM. TUG-424 significantly increases glucose-stimulated insulin secretion at 100 nM. TUG-424 may serve to explore the role of FFA1 in metabolic diseases such as diabetes or obesity . TUG-424 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Referencia número: HY-19842
No. CAS: 618380-90-8
Synonyms: CVT 3619
Target:  

Adenosine Receptor

Áreas de investigación:  

Cardiovascular Disease Metabolic Disease

GS-9667 (CVT 3619), a novel N 6-5'-substituted adenosine analog, is a selective, partial agonist of the A1 adenosine receptor (A1AdoR). GS-9667 binds to adipocyte membranes with high (KH=14 nM) and low (KL=5.4 μM) affinities. GS-9667 reduces cyclic AMP content and release of nonesterified fatty acids from epididymal adipocytes with IC50 values of 6 nM and 44 nM, respectively. GS-9667 inhibits lipolysis and has the potential for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA) .
loading...
    loading...